arrow
Back
M

Matthias Christgen

Hannover Medical School

38H-index
245Paper Count
5.3KCitation Count
Published Papers 97
Publication Date
Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy
err2026-04-23
err0
errOAAI
errAnnika Nasdala; Leonie D Kandt; Martin Radner; Nora Schaumann; Malte Gronewold; Pia Hillmann; Henriette Christgen; Jens Hachenberg; Elna Kuehnle; Christian Hartmann; Matthias Christgen
errShare
errSave
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT
err2026-02-01
err0
PREAI
errBraun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia
errShare
errSave
Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer
err2025-11-21
err0
errOAAI
errG. Zhang; H. Ni; L. Mishieva; S. Bartels; M. Christgen; H. Christgen; L.D. Kandt; M. Raap; R.E. Kates; O. Gluz; M. Graeser; S. Kümmel; U. Nitz; C. Plass; U. Mansmann; C. zu Eulenburg; C. Gerhäuser; H.H. Kreipe; N. Harbeck
errShare
errSave
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®)
err2025-11-19
err0
errOAAI
errAlexander Scheiter; Sven Mattern; Verena Gassenmaier; Hans-Ulrich Schildhaus; Matthias Christgen; Hans Kreipe; Hermann Herbst; Bettina Lambert; Guido Sauter; Maximilian Lennartz; Korinna Jöhrens; Florian Sperling; Afschin Soleiman; Ramona Erber; Stephan Singer; Annette Staebler; Kirsten Utpatel
errShare
errSave
The Janus Face of SPAG6: Inducing EMT in Luminal Breast Cancer Cells Amidst Widespread Expression Loss in Breast Tumours
err2025-10-09
err0
errOAAI
errAntonio Sechi; Jolein Mijnes; Sophia Villwock; Michael Rose; Florian Steib; Sarah Bringezu; Jonas Berger; Carmen Schalla; Sonja von Serenyi; Jana Dietrich; Nadina Ortiz-Brüchle; Lara Heij; Jan Bednarsch; Oleg Gluz; Ulrike Nitz; Nadia Harbeck; Monika Graeser; Christine zu Eulenburg; Mohammad Parsa Mohammadian; Katarzyna Jóźwiak; Hans-Heinrich Kreipe; Matthias Christgen; Martin Radner; Danny Jonigk; Edgar Dahl
errShare
errSave
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders
err2025-10-01
err2
errOAAI
errZhang, Guokun; Jurinovic, Vindi; Bartels, Stephan; Christgen, Matthias; Christgen, Henriette; Kandt, Leonie Donata; Mishieva, Lidiya; Ni, Hua; Raap, Mieke; Klein, Janin; Katzke, Anna-Lena; Hofmann, Winfried; Steinemann, Doris; Kates, Ronald E.; Gluz, Oleg; Graeser, Monika; Kummel, Sherko; Nitz, Ulrike; Plass, Christoph; Lehmann, Ulrich; Eulenburg, Christine zu; Mansmann, Ulrich; Gerhauser, Clarissa; Harbeck, Nadia; Kreipe, Hans H.
errShare
errSave
Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breast
err2025-07-03
err0
errOAAI
errGiuseppe Floris; Lounes Djerroudi; Gitte Zels; Maxim De Schepper; François Richard; Rigleta Brahimaj; Patrick W.B. Derksen; Matthias Christgen; Sunil R. Lakhani; Paul J. Van Diest; Edi Brogi; Christine Desmedt; Stuart J. Schnitt; Anne Vincent-Salomon;
errShare
errSave
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial
err2025-06-01
err0
errOAAI
errRadner, Martin; Burmeister, Sandy; Jozwiak, Katarzyna; Schaumann, Nora; Gronewold, Malte; Raap, Mieke; Bartels, Stephan; Christgen, Henriette; Kandt, Leonie D.; Hillmann, Pia; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; zu Eulenburg, Christine; Harbeck, Nadia; Kreipe, Hans; Christgen, Matthias
errShare
errSave
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial
err2025-03-26
err0
errOAAI
errKorbie, Darren; Stirzaker, Clare; Gluz, Oleg; zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J.; Trau, Matt; Graeser, Monika; Harbeck, Nadia
errShare
errSave
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
err2025-02-26
err0
errOAAI
errRichters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E.; Grischke, Eva-Maria; Altmueller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C.; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K.; Hahnen, Eric; Harbeck, Nadia
errShare
errSave
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
err2025-02-14
err0
errOAAI
errSchmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kuemmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Luedtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jozwiak, Katarzyna; Burmeister, Sandy; zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia; West German Study Grp Investigators
errShare
errSave
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
err2025-01-24
err0
errOAAI
errHaeberle, Lothar; Erber, Ramona; Gass, Paul; Hein, Alexander; Niklos, Melitta; Volz, Bernhard; Hack, Carolin C.; Schulz-Wendtland, Ruediger; Huebner, Hanna; Goossens, Chloe; Christgen, Matthias; Doerk, Thilo; Park-Simon, Tjoung-Won; Schneeweiss, Andreas; Untch, Michael; Nekljudova, Valentina; Loibl, Sibylle; Hartmann, Arndt; Beckmann, Matthias W.; Fasching, Peter A.
errShare
errSave
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
err2024-07-01
err5
errOAAI
errDe Schepper, Maxim; Koorman, Thijs; Richard, Francois; Christgen, Matthias; Vincent-Salomon, Anne; Schnitt, Stuart J.; van Diest, Paul J.; Zels, Gitte; Mertens, Freya; Maetens, Marion; Vanden Bempt, Isabelle; Harbeck, Nadia; Nitz, Ulrike; Graser, Monika; Kuemmel, Sherko; Gluz, Oleg; Weynand, Birgit; Floris, Giuseppe; Derksen, Patrick W. B.; Desmedt, Christine
errShare
errSave
Individual patient data meta-analysis of clinical and translational biomarkers for prediction of pathological complete response (pCR) after de-escalated therapy in HER2+breast cancer in four trials of the West German Study Group
err2024-05-02
err0
PREAI
errGraeser, Monika; Gluz, Oleg; zu Eulenburg, Christine; Kuemmel, Sherko; von Schumann, Raquel; Christgen, Matthias; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans-Heinrich; Schmid, Peter; Thill, Marc; Braun, Michael; Potenberg, Jochem; Schumacher, Claudia; Tio, Joke; Hartkopf, Andreas; Just, Marianne; Schem, Christian; Ludtke-Heckenkamp, Kerstin; Grischke, Eva-Maria; Hilpert, Felix; Kentsch, Angela; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia
errShare
errSave
PROOFS - Pre/perimenopausal patients with HR+/HER2-EBC with intermediate to high clinical and low genomic risk, treated by endocrine treatment (ET) plus ovarian function suppression (OFS) or chemotherapy followed by ET
err2024-05-02
err0
PREAI
errWuerstlein, Rachel; Fischer, Lotta Ada; Harbeck, Nadia; Graeser, Monika; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; zu Eulenburg, Christine; Warm, Matthias; Gluz, Oleg
errShare
errSave
Multi-modal artificial intelligence models from baseline histopathology predict prognosis in HR+HER2-early breast cancer
err2024-05-02
err0
PREAI
errKates-Harbeck, Daniel; Kreipe, Hans-Heinrich; Gluz, Oleg; Christgen, Matthias; Kuemmel, Sherko; Graeser, Monika; Nitz, Ulrike; Mahner, Sven; Mayr, Doris; Wuerstlein, Rachel; Mitani, Akinori; Zhang, Jingbin; Pinckaers, Hans; Ren, Yi; Wood, Peter; Griffin, Jacqueline; Feng, Felix; Esteva, Andre; Keim-Malpass, Jess; Kates, Ronald; Harbeck, Nadia
errShare
errSave
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)
err2024-05-02
err0
PREAI
errGluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; zu Eulenburg, Christine; Jozwiak, Katarzyna; Burmeister, Sandy; Baehner, Rick; Schmid, Peter; Kreipe, Hans-Heinrich; Harbeck, Nadia
errShare
errSave
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)
err2024-05-02
err0
PREAI
errGluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; Eulenburg, Christine Zu; Schmid, Peter; Baehner, Rick; Kreipe, Hans-Heinrich; Harbeck, Nadia
errShare
errSave
HER2DX genomic assay in triple-negative breast cancer (TNBC) patients treated with 12-weeks of neoadjuvant chemotherapy: a correlative analysis from WSGADAPT-TN phase II trial
err2024-05-02
err0
PREAI
errGluz, Oleg; Braso-Maristany, Fara; Nitz, Ulrike; Pare, Laia; Christgen, Matthias; Villacampa, Guillermo; Conte, Benedetta; Kuemmel, Sherko; Kates, Ronald; Kolberg-Liedtke, Cornelia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Vivancos, Ana; Wuerstlein, Rachel; Parker, Joel S.; Graeser, Monika; Perou, Charles M.; zu Eulenburg, Christine; Villagrasa, Patricia; Kreipe, Hans-Heinrich; Prat, Aleix; Harbeck, Nadia
errShare
errSave